Logo image of HIMS

HIMS & HERS HEALTH INC (HIMS) Stock Fundamental Analysis

NYSE:HIMS - New York Stock Exchange, Inc. - US4330001060 - Common Stock

29.81  +1.96 (+7.04%)

After market: 29.86 +0.05 (+0.17%)

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to HIMS. HIMS was compared to 108 industry peers in the Health Care Providers & Services industry. HIMS is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. HIMS has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

HIMS had positive earnings in the past year.
In the past year HIMS had a positive cash flow from operations.
In the past 5 years HIMS reported 4 times negative net income.
HIMS had negative operating cash flow in 4 of the past 5 years.
HIMS Yearly Net Income VS EBIT VS OCF VS FCFHIMS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 0 50M -50M -100M

1.2 Ratios

HIMS has a Return On Assets of 16.81%. This is amongst the best in the industry. HIMS outperforms 98.13% of its industry peers.
The Return On Equity of HIMS (23.01%) is better than 92.52% of its industry peers.
HIMS has a Return On Invested Capital of 7.89%. This is in the better half of the industry: HIMS outperforms 77.57% of its industry peers.
Industry RankSector Rank
ROA 16.81%
ROE 23.01%
ROIC 7.89%
ROA(3y)-16.29%
ROA(5y)-9.96%
ROE(3y)-20.03%
ROE(5y)-12.22%
ROIC(3y)N/A
ROIC(5y)N/A
HIMS Yearly ROA, ROE, ROICHIMS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 0 -10 -20 -30

1.3 Margins

With an excellent Profit Margin value of 8.15%, HIMS belongs to the best of the industry, outperforming 88.78% of the companies in the same industry.
The Operating Margin of HIMS (3.62%) is comparable to the rest of the industry.
With an excellent Gross Margin value of 81.13%, HIMS belongs to the best of the industry, outperforming 93.46% of the companies in the same industry.
Industry RankSector Rank
OM 3.62%
PM (TTM) 8.15%
GM 81.13%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
HIMS Yearly Profit, Operating, Gross MarginsHIMS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 0 20 -20 40 60 80

More info and screens

7

2. Health

2.1 Basic Checks

HIMS has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, HIMS has more shares outstanding
There is no outstanding debt for HIMS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
HIMS Yearly Shares OutstandingHIMS Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 50M 100M 150M 200M
HIMS Yearly Total Debt VS Total AssetsHIMS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 100M 200M 300M 400M

2.2 Solvency

An Altman-Z score of 24.54 indicates that HIMS is not in any danger for bankruptcy at the moment.
The Altman-Z score of HIMS (24.54) is better than 98.13% of its industry peers.
There is no outstanding debt for HIMS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 24.54
ROIC/WACC0.85
WACC9.25%
HIMS Yearly LT Debt VS Equity VS FCFHIMS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 0 100M 200M 300M

2.3 Liquidity

A Current Ratio of 2.14 indicates that HIMS has no problem at all paying its short term obligations.
The Current ratio of HIMS (2.14) is better than 73.83% of its industry peers.
HIMS has a Quick Ratio of 1.82. This is a normal value and indicates that HIMS is financially healthy and should not expect problems in meeting its short term obligations.
HIMS has a better Quick ratio (1.82) than 71.03% of its industry peers.
Industry RankSector Rank
Current Ratio 2.14
Quick Ratio 1.82
HIMS Yearly Current Assets VS Current LiabilitesHIMS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 50M 100M 150M 200M 250M

More info and screens

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 358.82% over the past year.
The Revenue has grown by 56.70% in the past year. This is a very strong growth!
EPS 1Y (TTM)358.82%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%900%
Revenue 1Y (TTM)56.7%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%77.13%

3.2 Future

HIMS is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 72.47% yearly.
Based on estimates for the next years, HIMS will show a very strong growth in Revenue. The Revenue will grow by 32.09% on average per year.
EPS Next Y608.15%
EPS Next 2Y164.61%
EPS Next 3Y104.85%
EPS Next 5Y72.47%
Revenue Next Year68.1%
Revenue Next 2Y53.04%
Revenue Next 3Y39.97%
Revenue Next 5Y32.09%

3.3 Evolution

HIMS Yearly Revenue VS EstimatesHIMS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2B 4B 6B
HIMS Yearly EPS VS EstimatesHIMS Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 1 2

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 67.75 indicates a quite expensive valuation of HIMS.
HIMS's Price/Earnings ratio is in line with the industry average.
Compared to an average S&P500 Price/Earnings ratio of 28.29, HIMS is valued quite expensively.
Based on the Price/Forward Earnings ratio of 54.18, the valuation of HIMS can be described as expensive.
The rest of the industry has a similar Price/Forward Earnings ratio as HIMS.
HIMS's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 24.44.
Industry RankSector Rank
PE 67.75
Fwd PE 54.18
HIMS Price Earnings VS Forward Price EarningsHIMS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of HIMS is on the same level as its industry peers.
Based on the Price/Free Cash Flow ratio, HIMS is valued a bit cheaper than the industry average as 62.62% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 43.53
EV/EBITDA 98.01
HIMS Per share dataHIMS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4 5

4.3 Compensation for Growth

HIMS's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as HIMS's earnings are expected to grow with 104.85% in the coming years.
PEG (NY)0.11
PEG (5Y)N/A
EPS Next 2Y164.61%
EPS Next 3Y104.85%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for HIMS!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

HIMS & HERS HEALTH INC

NYSE:HIMS (1/21/2025, 8:05:33 PM)

After market: 29.86 +0.05 (+0.17%)

29.81

+1.96 (+7.04%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-04 2024-11-04/amc
Earnings (Next)N/A N/A
Inst Owners65.92%
Inst Owner Change0.11%
Ins Owners11.56%
Ins Owner Change4.1%
Market Cap6.51B
Analysts72.38
Price Target27.86 (-6.54%)
Short Float %28.28%
Short Ratio2.92
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)352.27%
Min EPS beat(2)37.66%
Max EPS beat(2)666.87%
EPS beat(4)4
Avg EPS beat(4)291.33%
Min EPS beat(4)37.66%
Max EPS beat(4)666.87%
EPS beat(8)7
Avg EPS beat(8)155.53%
EPS beat(12)9
Avg EPS beat(12)95.7%
EPS beat(16)11
Avg EPS beat(16)66.46%
Revenue beat(2)2
Avg Revenue beat(2)3.09%
Min Revenue beat(2)3%
Max Revenue beat(2)3.17%
Revenue beat(4)3
Avg Revenue beat(4)1.24%
Min Revenue beat(4)-2.07%
Max Revenue beat(4)3.17%
Revenue beat(8)6
Avg Revenue beat(8)1.45%
Revenue beat(12)10
Avg Revenue beat(12)3.73%
Revenue beat(16)13
Avg Revenue beat(16)-2.61%
PT rev (1m)9.97%
PT rev (3m)24.57%
EPS NQ rev (1m)0%
EPS NQ rev (3m)239.41%
EPS NY rev (1m)0%
EPS NY rev (3m)138.26%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)41.04%
Revenue NY rev (1m)0.07%
Revenue NY rev (3m)5.43%
Valuation
Industry RankSector Rank
PE 67.75
Fwd PE 54.18
P/S 5.24
P/FCF 43.53
P/OCF 34.89
P/B 14.8
P/tB 23.05
EV/EBITDA 98.01
EPS(TTM)0.44
EY1.48%
EPS(NY)0.55
Fwd EY1.85%
FCF(TTM)0.68
FCFY2.3%
OCF(TTM)0.85
OCFY2.87%
SpS5.68
BVpS2.01
TBVpS1.29
PEG (NY)0.11
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 16.81%
ROE 23.01%
ROCE 9.99%
ROIC 7.89%
ROICexc 18.14%
ROICexgc 93.35%
OM 3.62%
PM (TTM) 8.15%
GM 81.13%
FCFM 12.05%
ROA(3y)-16.29%
ROA(5y)-9.96%
ROE(3y)-20.03%
ROE(5y)-12.22%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover2.06
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 270.83%
Cap/Sales 2.98%
Interest Coverage 250
Cash Conversion 318.65%
Profit Quality 147.76%
Current Ratio 2.14
Quick Ratio 1.82
Altman-Z 24.54
F-Score7
WACC9.25%
ROIC/WACC0.85
Cap/Depr(3y)166.09%
Cap/Depr(5y)N/A
Cap/Sales(3y)2.09%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)358.82%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%900%
EPS Next Y608.15%
EPS Next 2Y164.61%
EPS Next 3Y104.85%
EPS Next 5Y72.47%
Revenue 1Y (TTM)56.7%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%77.13%
Revenue Next Year68.1%
Revenue Next 2Y53.04%
Revenue Next 3Y39.97%
Revenue Next 5Y32.09%
EBIT growth 1Y222.67%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year613.95%
EBIT Next 3Y125.48%
EBIT Next 5Y73.97%
FCF growth 1Y615.27%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y914.6%
OCF growth 3YN/A
OCF growth 5YN/A